发明公开
EP1626727A1 APPLICATION OF 2-CYANO-10- (2-METHYL-3- (METHYLAMINO)- PROPYL) PHENOTHIAZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT AS MEDICAMENT
有权
使用2-氰基 - 10-（2-甲基-3-（甲基氨基） - 丙基）吩噻嗪或其药物上可接受的盐作为药物
- 专利标题： APPLICATION OF 2-CYANO-10- (2-METHYL-3- (METHYLAMINO)- PROPYL) PHENOTHIAZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT AS MEDICAMENT
- 专利标题（中）： 使用2-氰基 - 10-（2-甲基-3-（甲基氨基） - 丙基）吩噻嗪或其药物上可接受的盐作为药物
-
申请号： EP04709051.9申请日： 2004-02-06
-
公开(公告)号： EP1626727A1公开(公告)日： 2006-02-22
- 发明人: DIB, Michel , HAMEG, Ahcene
- 申请人： AVENTIS PHARMACEUTICALS INC.
- 申请人地址： 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807-2854 US
- 专利权人： AVENTIS PHARMACEUTICALS INC.
- 当前专利权人： AVENTIS PHARMACEUTICALS INC.
- 当前专利权人地址： 300 Somerset Corporate Boulevard Bridgewater, New Jersey 08807-2854 US
- 代理机构： Rousseau, Pierrick Edouard
- 优先权： FR0301440 20030207; US459812P 20030402
- 国际公布： WO2004071512 20040826
- 主分类号： A61K31/5415
- IPC分类号： A61K31/5415 ; A61P25/00
摘要：
The present invention relates to the application of 2-cyano-10-(2-methyl-3-(methylamino)propyl)phenothiazine or a pharmaceutically acceptable salt of this compound to produce a medicament intended for the treatment of sleep disorders, anxiety disorders, mood disorders, mixed anxiety-depression disorder, acute and chronic psychotic state, addiction to and withdrawal from a substance, extrapyramidal events induced by antipsychotics, or symptomatic dimensions during acute or chronic psychotic states as monotherapy or in combination with other antipsychotics.
公开/授权文献
信息查询
IPC分类:
